Table 5.

Relationship between RC and GDM risk in different sensitivity analyses

	Exposure	Participants(n)	Non-GDM	GDM	Odds ratio (95% CI)	P value
Model I	RC (mg/dL)	492	22.51 ± 8.32	38.95 ± 22.48	+ 5 mg/dL: 1.473 (1.200, 1.809)	< 0.001
Model II	RC (mg/dL)	479	23.03 ± 8.34	37.31 ± 18.63	+ 5 mg/dL: 1.511 (1.211, 1.885)	< 0.001

Model I was a sensitivity analysis after excluding those with pre-pregnancy BMI ≥ 25 kg/m². We adjusted for age, pre-pregnancy BMI, hepatic steatosis, AST, GGT, ALT, FPG, adiponectin, and insulin

Model II was a sensitivity analysis, including those with grade 0 hepatic steatosis. We adjusted for age, pre-pregnancy BMI, AST, GGT, ALT, FPG, adiponectin, and insulin